The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 192 | 2022 |
Application of machine learning techniques to tuberculosis drug resistance analysis S Kouchaki, Y Yang, TM Walker, A Sarah Walker, DJ Wilson, TEA Peto, ... Bioinformatics 35 (13), 2276-2282, 2019 | 93 | 2019 |
Extended-Spectrum ß-Lactamase, AmpC-Producing, and Fluoroquinolone-Resistant Escherichia coli in Retail Broiler Chicken Meat, Italy A Ghodousi, C Bonura, AM Di Noto, C Mammina Foodborne pathogens and disease 12 (7), 619-625, 2015 | 91 | 2015 |
Clofazimine: A useful antibiotic for drug-resistant tuberculosis R Mirnejad, A Asadi, S Khoshnood, H Mirzaei, M Heidary, L Fattorini, ... Biomedicine & Pharmacotherapy 105, 1353-1359, 2018 | 77 | 2018 |
Acquisition of cross-resistance to bedaquiline and clofazimine following treatment for tuberculosis in Pakistan A Ghodousi, AH Rizvi, AQ Baloch, A Ghafoor, FM Khanzada, M Qadir, ... Antimicrobial agents and chemotherapy 63 (9), 10.1128/aac. 00915-19, 2019 | 69 | 2019 |
Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis CRyPTIC Consortium European Respiratory Journal 60 (4), 2022 | 58 | 2022 |
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid A Bateson, J Ortiz Canseco, TD McHugh, AA Witney, S Feuerriegel, ... Journal of Antimicrobial Chemotherapy 77 (6), 1685-1693, 2022 | 55 | 2022 |
DeepAMR for predicting co-occurrent resistance of Mycobacterium tuberculosis Y Yang, TM Walker, AS Walker, DJ Wilson, TEA Peto, DW Crook, ... Bioinformatics 35 (18), 3240-3249, 2019 | 54 | 2019 |
Isoniazid Resistance in Mycobacterium tuberculosis Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying … A Ghodousi, E Tagliani, E Karunaratne, S Niemann, J Perera, CU Köser, ... Antimicrobial agents and chemotherapy 63 (7), 10.1128/aac. 00092-19, 2019 | 53 | 2019 |
The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis M Heidary, S Zaker Bostanabad, SM Amini, A Jafari, M Ghalami Nobar, ... Infection and Drug Resistance, 3425-3435, 2019 | 51 | 2019 |
Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011 M Haeili, A Ghodousi, B Nomanpour, M Omrani, MM Feizabadi The Journal of Infection in Developing Countries 7 (04), 312-317, 2013 | 47 | 2013 |
Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries AM Cabibbe, A Trovato, MR De Filippo, A Ghodousi, L Rindi, C Garzelli, ... European Respiratory Journal 51 (6), 2018 | 43 | 2018 |
GenomegaMap: Within-Species Genome-Wide dN/dS Estimation from over 10,000 Genomes CC Daniel J Wilson Molecular Biology and Evolution 37 (8), 2450-2460, 2020 | 38* | 2020 |
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis L Sonnenkalb, JJ Carter, A Spitaleri, Z Iqbal, M Hunt, KM Malone, ... The Lancet Microbe 4 (5), e358-e368, 2023 | 35 | 2023 |
Single tube real time PCR for detection of Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella pneumophila from … B Nomanpour, A Ghodousi, T Babaei, S Jafari, M Feizabadi Acta microbiologica et immunologica Hungarica 59 (2), 171-184, 2012 | 32 | 2012 |
Rapid, cost-effective, sensitive and quantitative detection of Acinetobacter baumannii from pneumonia patients B Nomanpour, A Ghodousi, A Babaei, HR Abtahi, M Tabrizi, ... Iranian journal of microbiology 3 (4), 162, 2011 | 31 | 2011 |
Tuberculosis: current challenges and beyond R Villar-Hernández, A Ghodousi, O Konstantynovska, R Duarte, C Lange, ... Breathe 19 (1), 2023 | 30 | 2023 |
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene … CRyPTIC Consortium, JJ Carter bioRxiv, 2021.09. 14.460353, 2021 | 30* | 2021 |
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai … V Dreyer, A Mandal, P Dev, M Merker, I Barilar, C Utpatel, K Nilgiriwala, ... Genome medicine 14 (1), 95, 2022 | 28 | 2022 |
Whole genome sequencing results associated with minimum inhibitory concentrations of 14 anti-tuberculosis drugs among rifampicin-resistant isolates of Mycobacterium … J Kardan-Yamchi, H Kazemian, S Battaglia, H Abtahi, ... Journal of Clinical Medicine 9 (2), 465, 2020 | 24 | 2020 |